相关实验视频
Updated: Jan 14, 2026

07:40
Multi-Modal Home Sleep Monitoring in Older Adults
Published on: January 26, 2019
8.1K
老年人的死亡率跨多种疾病类别和生活方式模式
Rafael Ogaz-González1, Qian Zou1, Javier Maroto-Rodriguez2
1University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, The Netherlands.
Aging and disease
|January 12, 2026
概括
生活方式模式显著影响了老年人多病症的死亡风险. 特定的疾病组合带来更高的风险,特别是在更健康的人群中,突出了针对性干预的必要性.
科学领域:
- 老年学是指老年学的学科.
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 在老年人中,多病症很普遍,特定的慢性疾病组合增加了死亡风险.
- 不健康的生活方式行为与预期寿命的缩短有关.
- 了解生活方式如何改变多病症对死亡率的影响,对于有效的干预至关重要.
研究的目的:
- 研究生活方式模式 (LPs) 对多病态配置 (MCs) 与老年人全因死亡率之间的关联的修改效应.
- 为了比较不同多重疾病概况与简单疾病计数的预后值.
主要方法:
- 分析了生命线队列中20853名老年人 (≥60岁) 的数据,平均随访时间为12年.
- 使用隐性类分析识别了五种不同的生活方式模式.
- 使用疾病计数 (≥2种非传染性疾病) 和五种潜伏多病症配置来定义多病症.
- 使用卡普兰-梅尔图表和考克斯模型估计全因死亡率,按生活方式模式分层.
主要成果:
- 死亡风险在不同的多病态配置中有显著差异,相关性取决于生活方式模式.
- 在"以健康平衡的方式"生活方式组中",复杂治疗"和"心血管疾病和血管疾病"配置显示死亡风险最高.
- 根据疾病计数定义的多病症表明,与特定配置相比,生活方式模式的影响大小的变化较小.
- 跨多病变性配置的风险变化在更健康的生活方式组中更为明显.
结论:
- 生活方式模式在塑造具有多病症的老年人死亡风险方面发挥着重要作用.
- 特定的多病症配置,而不是仅仅是疾病数量,提供更大的预后价值.
- 研究结果支持个性化风险评估和有针对性的干预措施,同时考虑多重疾病概况和生活方式.
相关概念视频
Lifestyle Factors and Health
406
Lifestyle factors play a critical role in maintaining overall health and preventing chronic diseases. Key elements, such as regular physical activity, a nutritious diet, and abstinence from smoking, can significantly enhance physical, mental, and emotional well-being while reducing the risk of several life-threatening conditions.
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
406
Pharmacodynamics in Geriatric Patients: Effects of Age
183
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
183
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
194
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
194
Drug Dosing: Geriatric Patients
219
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
219
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
223
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
223
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
232
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
232

